|
|
||||||||||
Assistant in Medicine, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Director of Pharmacy, Partners Community HealthCare, Inc., Needham, MA
Professor of Medicine, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School
Assistant Professor of Medicine, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School
Reprints: Richard W Grant MD MPH, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 50 Staniford St., Boston, MA 02114-2517, FAX 617/724-3544, E-mail rgrant{at}partners.org
OBJECTIVE: To improve medication adherence by reducing self-reported adherence barriers, and to identify medication discrepancies by comparing physician-prescribed and patient-reported medical regimens.
DESIGN: Prospective, randomized, controlled trial.
SETTING AND PARTICIPANTS: A single academically affiliated community health center. Eligible patients had type 2 diabetes, had undergone laboratory testing in the year preceding the study, and had visited the clinic in the 6 months preceding the study.
INTERVENTION: A pharmacist administered detailed questionnaires, provided tailored education regarding medication use and help with appointment referrals, and created a summary of adherence barriers and medication discrepancies that was entered into the medical record and electronically forwarded to the primary care provider.
MEASUREMENTS: Changes in self-reported adherence rates and barriers were compared 3 months after the initial interview. Intervention patients with medication discrepancies at baseline were assessed for resolution of discrepancies at 3 months.
RESULTS: Rates of self-reported medication adherence were very high and did not improve further at 3 months (6.9 of 7 d, with all medicines taken as prescribed; p = 0.3). Medical regimen discrepancies were identified in 44% of intervention patients, involving 45 doses of medicines. At 3-month follow-up, 60% of discrepancies were resolved by corrections in the medical record, while only 7% reflected corrections by patients.
CONCLUSIONS: In this community cohort, patients reported few adherence barriers and very high medication adherence rates. Our patient-tailored intervention did not further reduce these barriers or improve self-reported adherence. The high prevalence of medication discrepancies appeared to mostly reflect inaccuracies in the medical record rather than patient errors.
Key Words: adherence, randomized controlled trial, type 2 diabetes mellitus
Published Online, May 23, 2003. www.theannals.com, DOI 10.1345/aph.1C452
This article has been cited by other articles:
![]() |
S. L. Swanlund, K. A. Scherck, S. A. Metcalfe, and S. R. Jesek-Hale Keys to Successful Self-Management of Medications Nurs Sci Q, July 1, 2008; 21(3): 238 - 246. [Abstract] [PDF] |
||||
![]() |
J. Tjia, J. L. Givens, J. H. Karlawish, A. Okoli-Umeweni, and F. K. Barg Beneath the surface: discovering the unvoiced concerns of older adults with Type 2 diabetes mellitus Health Educ. Res., February 1, 2008; 23(1): 40 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Odegard and K. Capoccia Medication Taking and Diabetes: A Systematic Review of the Literature The Diabetes Educator, November 1, 2007; 33(6): 1014 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Orwig, N. Brandt, and A. L. Gruber-Baldini Medication management assessment for older adults in the community. Gerontologist, October 1, 2006; 46(5): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mino-Leon, A. Figueras, D. Amato, and J.-R. Laporte Treatment of Type 2 Diabetes in Primary Health Care: A Drug Utilization Study Ann. Pharmacother., March 1, 2005; 39(3): 441 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Van Wijk, O. H Klungel, E. R Heerdink, and A. de Boer Effectiveness of Interventions by Community Pharmacists to Improve Patient Adherence to Chronic Medication: A Systematic Review Ann. Pharmacother., February 1, 2005; 39(2): 319 - 328. [Abstract] [Full Text] [PDF] |
||||